Clinical Trials Browser

Has results × Carcinoma, Intraductal, Noninfiltrating × afimoxifene × Clear all

NCT02993159 2024-12-18

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

Phase 2 Completed

100 enrolled 15 charts

Carcinoma, Intraductal, Noninfiltrating

NCT00952731 2015-07-21

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Phase 2 Completed

27 enrolled 12 charts

Carcinoma, Intraductal, Noninfiltrating